Altogether, this explanation is in accordance with our findings in which increased resistin and decreased irisin levels in obese children and in those with MS may both compromise glucose uptake in peripheral tissues, thereby aggravating a metabolic condition. This evidence concerns the gene FNDC5 and myeloid sarcoma.